Introduction
The Gram-negative and opportunistic pathogen Pseudomonas aeruginosa is am ajor threat to hospitalized and immune-compromised patients. [1] Unfortunately,m any hospital strainsa re getting largely unaffected by many antibiotics. [2] This resistance results from the presence of drug-neutralizing tools in P. aeruginosa,f or example, beta-lactamases or efflux pumps, but also from its potential tof orm biofilms.I nt hese biofilms, bacteria are embedded in as elf-produced matrix, which protects againsth ost immune defense and antibiotic treatment. [3, 4] Twol ectins produced by P. aeruginosa,L ecA (PA-IL) and LecB (PA-IIL), play key roles in biofilm formation,a nd both lectins are virulence factors involved in host damage and bacterial uptake. [5] [6] [7] [8] [9] [10] Inhibition of these lectins as an anti-infectives trategy belongs to the new concept of antivirulence therapies. [11] In contrast to antibiotics targetingb acterialv iability,a ntivirulence therapeuticss olely target the infection withouti nterference on viability and therefore the appearance of resistant mutants is decreased. [12] In ap roof of concepts tudy for therapeutic suitability of the lectins LecA andL ecB as target, Hauber et al. could show ad ecrease in bacterial load after treatment of pulmonary-infected patientsw ith an aerosol containing natural ligandsofb oth lectins. [13] The carbohydrate-binding protein LecB was first isolated by Gilboa-Garber et al.,a nd its glycan preference was determined. [14, 15] The crystal structure of LecB in complex with its high-affinity ligand l-fucose revealed the presence of two calcium ions, which mediate binding between the saccharide and the protein. [16] As ubsequent study could show that the loweraffinity ligand d-mannose binds similarly to LecB as ac onsequenceo ft hree hydroxy groups with identical relative orientation in both l-fucose and d-mannose. [17] The trisaccharide Lewis a was identified from glycan array analysisand is currently its best known monovalentl igand with at hermodynamic dissociation constant of 210 nm. [18, 19] Numerous multivalent inhibPseudomonas aeruginosa is an opportunistic Gram-negative pathogen with high antibiotic resistance. Its lectin LecB was identified as av irulence factor and is relevanti nb acterial adhesion and biofilm formation. Inhibition of LecB with carbohydrate-based ligands results in ad ecrease in toxicitya nd biofilm formation. We recently discoveredt wo classes of potent druglike glycomimetic inhibitors, that is, sulfonamides and cinnamides of d-mannose. Here, we describet he chemical synthesis and biochemical evaluationo fm ore than 20 derivatives with increased potency compared to the unsubstituted cinnamide.
The structure-activity relationship (SAR) obtained and the extendedb iophysical characterization allowed the experimental determination of the binding mode of these cinnamides with LecB. The established surfaceb inding mode now allows future rational structure-based drug design. Importantly,a ll glycomimeticst ested showed extended receptor residence times with half-lives in the 5-20 min range, ap rerequisite for therapeutic application.Thus, the glycomimeticsdescribed here provide an excellentb asis for future development of anti-infectives againstt his multidrug-resistant pathogen.
itors of LecB based on conjugates of natural l-fucose have been reported to date in order to further increase binding affinities. [20, 21] One multivalent fucosylated peptided endrimer was shown to be ah igh-affinity ligand with the potential to inhibit biofilm formation and disperse established biofilms of P. aeruginosa in aL ecB-dependent fashion. [22] In contrast, the development of monovalenti nhibitors has been largely neglected due to their intrinsically lower affinities and efforts are summarized in recent reviews. [23, 24] We recently reported the discovery of derivatives of d-mannose with amido-a nd sulfonamido substituents at position6 (2 and 3,F igure 1). [25] Compared with the parentl ow-affinity ligand methyl mannoside (1,F igure 1), [26] these modifications improved bindinga ffinity between four-and 24-fold. In contrast to a-l-fucosides, d-mannose as scaffold providedt he possibility to target an adjacentc left on the protein in order to increase binding affinity.B ecause in the crystal structure of LecB with d-mannose, [17] ah ydrogen bond between its 6-OH and Ser23 was observed, particular attention was paid to this hydroxy group in the design of new inhibitors. [25, 27, 28] However, we could show throughc hemical modification that this hydrogen bond does not have as ignificant influenceo nb inding affinity at ambient conditions in aqueous solution. [27, 28] In our previouss tudy,w es ucceeded in obtainingaco-crystal structure of sulfonamide 2 in complex with LecB. In the absence of ac rystal structure for cinnamide 3 in complex with LecB, molecular dynamics simulations and NMR suggested an intercalation of the cinnamide residue into the beta-sandwich of the lectin. [25] Here, we describe the synthesis of as et of more than 20 substituted cinnamido derivatives to establish the structureactivity relationship (SAR) of the interaction of this class of inhibitors with LecB. Furthermore, we used ad iverses et of differentb iophysical techniques to establish the binding mode of this class of LecB inhibitors.
Results and Discussion
In the predicted binding mode of cinnamide 3,t he aromatic moiety opens ac left in the protein and intercalates into the beta-sandwich formed by one LecB monomer.I no rder to get am ore detailed picture of the interaction of such cinnamides with LecB, we performed astructure-activity study with avariety of substituents in ortho-, meta-, and para-position of the cinnamic amide residueo f3.T he synthesis of the cinnamide derivatives startedf rom methyl a-d-mannoside (1). Introduction of an aminof unctional group allowed amide bond formation with unprotected mannosed erivative 4 with as et of selected commercially available cinnamic acid derivatives. Various substituentsw ere introduced in ortho-, meta-, or para-position resulting in the potential LecB inhibitors 5a-e, 5g-k,a nd 5m-q, respectively,w hich were obtainedi nm oderate to good yields (Scheme1). The nitro derivatives 5e, 5k,a nd 5q were further Figure 1 . Reportedn aturaland synthetically modified mannosebased inhibitors 1, 2,a nd 3 and their thermodynamic dissociation constants(K d )witht he lectin LecB. [25, 26] Scheme1.Synthesis of compounds 5a-r, 6,a nd 7a,b. Reagents and conditions:a)carboxylic acids, EDC·HCl,E t 3 N, DMF,08C ! rt;b)FeSO 4 ·7 H 2 O, NH 4 OH, H 2 O, rt;c )Pd/C,H 2 ,M eOH, rt. Reactiontimes, yields, and puritiesa re summarized in Ta ble S1 in the Supporting Information.
ChemistryOpen 2015, 4,756 -767 www.chemistryopen.org reduced with iron(II) sulfate following am ethod by Pribulova et al. [29] for aliphatic nitro groupst og ive the corresponding anilines 5f, 5l,a nd 5r in high yields. Furthermore, we synthesized the more rigid2 -naphtoyl derivative 6 as ac yclized analog of 3,a sw ell as the two disubstituted analogs 7a and 7b following the same protocol.
All synthesized compounds were then biochemically evaluated for inhibition of LecB using ac ompetitive binding assay based on fluorescencep olarization readout,r ecently developed for LecB in our lab. [25] Surprisingly,a ll monosubstituted compounds were within an arrow activity range with IC 50 values from 27-73 mm, indicating that the substituents tested had am oderate effect on the activity that remains similar to the parentc innamide 3 with an IC 50 of 37 mm (Figure 2 ). Introductiono fortho substituents in 5a-f generally resulted in weaker inhibition of LecB (IC 50 49-73 mm), while the same substituents in meta-o rpara-position (5g-l and 5m-r)s howed similar or enhanced potency with IC 50 values ranging from 27-53 mm.T he decreased affinity of ortho-substituted 5a-f might result from as terich indrance with the receptor.G enerally,t he introduction of polar substituents such as phenolich ydroxy groups or aniline-NH 2 led to adecreaseda ffinity (5b, 5f, 5h, 5l, 5n, 5r), whereas the presence of the lipophilic substituents chloro,m ethoxy,o rm ethyl resulted in enhanced potencies especially in meta or para position (5g, 5i, 5j,a nd 5m, 5o, 5p). Methoxy-substituted cinnamides were superior inhibitors in the ortho, meta,a nd para series,w ithh ighest potencies for meta-5i and para-5o.W e therefore combined both substituents in one molecule as 3,4-methylenedioxy derivative 7a or 3,4-dimethoxycinnamide 7b to analyze potential synergistic effects. Both compounds showedg ood inhibition of LecB with dimethoxy-substituted 7b as the most potent inhibitor at an IC 50 of 19.9 mm.M ethylenedioxy derivative 7a had an IC 50 of 29 mm,w hich was comparable to singly meta-o rpara-methoxy-substituted 5i and 5o.
In addition, we tested the cyclized analog 6 bearing a2 -naphtamide in lieu of the cinnamide moiety for LecB inhibition. In accordance with the general trend of higher affinities for more lipophilics ubstituentsa mong all tested compounds, compound 6 also displayed an increased inhibitory potency (IC 50 31 mm). The 2-naphtamide 6 is structurally similar to ortho-substituted cinnamides 5a-f,e specially to the 2-methyl derivative 5d.G enerally,s teric hindrance with the receptor, www.chemistryopen.org ad istorted planarity of the cinnamide moiety,o re ven af urther increaseo ft he already high rotational barrier due to the orthosubstituents in 5a-f could account for the decreaseda ffinity in the ortho-series.P ossible reasons for the differencei na ctivity between 6 and 5a-f cannot be deducedf rom the present data set. Although ar ather flat SAR on the substituents of the cinnamica cid moietyw as obtained, at wo-fold increase in potency compared to unsubstituted cinnamide 3 could be achieved through introduction of two methoxy substituents in meta-and para position in 7b.
Can this SAR at the cinnamide residue explain the previously proposed intercalation model of the binding of 3 to LecB? During our previouss tructuralc haracterization of the cinnamide 3-LecB interaction, we observed global line broadening of the protein signals at ap rotein-ligand ratio of 2:1; as toichiometric ratio of 1:1l ed to completevanishing of resonances and visual precipitation of protein after af ew hours of recording time. In contrast, the same analysis with sulfonamide 2 yielded distincts hifts of as malls et of protein resonances.T he protein NMR spectraw ere interpreted,s uch that the computationally predicted intercalation of 3 into the beta-sandwich of LecB leads to ag lobal effect on its structure and, thus, results in changes of most of the protein resonances.
In order to analyze whether the observed effects on LecB induced by cinnamide 3 are carbohydrate-specific and to exclude simple detergent-like denaturationo fthe protein, we designed its glucose-analog 10.T he compound was synthesized in analogy to 3:m ethyl a-d-glucoside (8)w as transformed into the tosylate and subsequently the azide 9 was obtained after sodium azide treatment as previously reported by Cramer et al. [30] (Scheme 2). The azide was hydrogenolytically reduced using palladium on activated charcoal, and the resulting amine was directly coupled with cinnamic acid to yield glucocinnamide 10 in good yield (46 %o ver two steps).
The control compound gluco-10 was then tested in the competitiveb inding assay to assess the carbohydrate-based specificity of cinnamide manno-3.N oi nhibitiono fL ecB function up to 3mm of gluco-cinnamide 10 was observed ( Figure 3 ), whereas manno-3 showed inhibition in ad ose-dependent mannera sp reviously reported. This assay relies on the displacemento fafucose-fluorescein conjugate as detection probe bound to intact LecB. The observed highf luorescence polarization even at high concentrations of gluco-10 therefore indicated persistent binding of the fluorescent probe and thus the absence of any kind of inhibitory influence of gluco-10 on LecB function. In summary,t here was no unspecific binding of the cinnamide moiety at elevated ligand concentrations, but the effects observed with manno-3 were instead dependent on the stereochemistry of one single hydroxy group and thus on the specific binding to the carbohydrate recognition site of LecB.
To further study the interaction of the mostp otent cinnamide with LecB, compound 7b was then titrated to LecB, and the thermodynamics of binding were analyzed by isothermal microcalorimetry (ITC, Figure 4 Subsequently,w ep erformed surfacep lasmon resonance (SPR) analysist od etermine the parameters of binding kinetics of LecB with its ligands. LecB was biotinylated using an activated carboxylic acid derivative of biotin and coupled to the surface of as treptavidin-coated sensor chip. High surface densities of LecB were obtained, which is necessary for the detection of small molecule binding. Methyl mannoside (1), sulfonamide 2,c innamide 3, and its derivative 7b,w hich showedt he highest potency among the cinnamide series in LecB inhibition, were analyzed by SPR ( Figure 5 , Ta ble 2). Unmodified mannoside 1 showed fast binding kinetics, which are usually observed with lectin-carbohydrate interactions. [31] The measured K d of 47 mm was in good agreement with the previously determined thermodynamic value of 71 mm by ITC. [26] Sulfonamide 2 showedatwo-fold highero n rate and av ery slow off rate of 6.2 10 À4 s
À1
.T he half-life (t 1/2 = ln2/k off )o ft he complex of LecB and sulfonamide 2 was 18.6 min, explaining its very high affinity (K d = 1.12 mm by SPR, 3.3 mm [25] by ITC) towards LecB compared to at 1/2 of only 45 sf or 1.I ti s important to note, that long drug-receptor half lives are important for in vivo functiona nd future success for drug development. [32, 33] When analyzing cinnamide 3,s low bindingk inetics approaching the detection limit of the apparatus were observed with a k on of 100.9 m À1 s
,w hich was threefold slower than mannoside 1 and more than fivefold slower than sulfonamide 2.I ts dimethoxy derivative 7b also showedaslow on rate with a k on of 169.6 m À1 s
,i ndicating as imilar mode of binding to LecB for 3 and 7b.T he dissociation constant of 18.1 mm for 3 was in very good agreement with its previously determined value of 18.5 mm [25] by calorimetry.T he most potent cinnamide derivatived imethoxycinnamide 7b showed a K d by SPR of 7.7 mm and ac omplex half-life t 1/ Table 1 . Thermodynamics of ligand bindingt oL ecB by isothermal titration microcalorimetry.V alues for 1-3 weret aken from the literature. [25, 26] Analysis of LecB andi ts complex with cinnamide by circular dichroism (CD) spectroscopyc ould yield insight on conformational changes induced by ligand binding. Interestinglyh owever,w ed id not observe significant differences in the CD spectra of LecB with 3 or LecB alone,a nd both spectraw ere indicative of beta-sheets as the predominant secondary structure (Figure 6A) . Then, at hermal denaturationo fL ecB in presence and absence of cinnamide 3 was performed to assess the influence of 3 on protein stability ( Figure 6B ). The CD spectrum of LecB was stable between 37 8Ca nd up to above 90 8C, and no defined melting point (T m )c ould be determined as shown in Figure 6B for the ellipticity at 229 nm. In presence of compound 3,o nly slightd ifferences were detected with somewhat bigger changes without ligand.F urther attempts to analyze T m of LecB with as et of compounds by thermals hift analysis using SYPRO Orange also failed to give signals for unfolded protein (data not shown). The lack of success in both thermal unfolding techniques presumably originates in the extraordinary high thermalstabilityo fLecB. [14] Based on the high degree of structurals imilarity of cinnamide 3 and dimethoxycinnamide 7b and their similar binding kinetics, we anticipated comparable binding modes and thus also as imilar behavior on protein NMR signals. Surprisingly, the 1 H, 15 N-TROSY-HSQC (transverse relaxation-optimized spectroscopy-heteronuclear single quantum coherence) NMR spectrum of 15 N-labelled LecB showed only distincts hifts of protein resonances in the presence of 7b,a nd even saturation of LecB with dimethoxycinnamide 7b couldb ea chieved at excellent quality of the spectra ( Figure 7B ). In contrast to our previously reported data for LecB in complex with the unsubstituted cinnamide 3,n og lobal vanishing of signal intensity was observed with dimethoxycinnamide 7b.T he behavior observed with 7b rather resembles the spectra obtained with sulfonamide 2 and thus ad istinctly defined binding site.
After an extensive search for crystallization conditions of LecB with cinnamide 3,w ef inally obtained protein crystals which diffracted to 1.6 a nd allowed structure determination ( Figure 8, Ta ble 3) . Both, the mannose part and the cinnamide residue were well defined and present in every binding site of the LecB tetramer ( Figure 8A ). Interestingly,t his crystal structure shows as urface binding of the cinnamide as opposed to the computational model suggesting the intercalation of the aromatic moiety into the protein. [25] The asymmetric unit contains one tetramer of LecB with one ligand molecule per monomer. In the overlay of ligand binding sites, ah igh variability between thel igand conformation in the four binding sites can be observed ( Figure 8A ). The mannose residue alwaysa dopts the same binding pose, whereas the cinnamide side chain is oriented in three different orientations. After closer examination of the structure, we identified extended p-p stacking contacts between the cinnamide part of two ligands from an eighboring LecB tetramer in the crystal lattice. In only one out of the four binding sites, the cinnamide substituent is in contact with the protein surface, forming van der Waals contacts with Gly97 and Thr98 and aw ater mediated hydrogen bond with Ser23 ( Figure 8B ). In the other three binding sites, the cinnamic acid residues forme xtended interligand p-p stacking contacts in the crystal lattice. It is well known that crystal lattice contactsc an induce certain conformationso fl igands or flexible regions in proteins, which sometimes do not occur in solution. [34] In solution, however,t he three binding modes lacking protein contact of the cinnamide are unlikely to occur.T he bindingm ode observedf or the fourth pose with the cinnamide having al ipophilic contact with the protein surface could explain the flat SAR, that is an arrow range of inhibitory activities, obtained.
In order to furtheru nderstandt he distinctly different characteristics of the interaction of LecB with the cinnamide ligands observed by protein NMR spectroscopy,w ea nalyzed inhibitormediated aggregation of LecB. Besides intermediate exchange phenomenao rp rotein unfolding, aggregationa lso leads to loss in observed signal intensityb yN MR spectroscopy.T o quantifyt he compounds' effect on protein aggregation, we Figure 6 . A) CD spectroscopy of LecB (35 mm)i nthe presence or absence of compound 3 (100 mm)g ave identicalCDs pectra indicative for beta-sheet secondarystructure. B) thermal unfolding followed by CD spectroscopyat 229 nm was not indicative of ad estabilizationoft he protein in presence of 3.
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www.chemistryopen.org performed titration experiments with ac onstant concentration of LecB and measured aggregation via light scattering at 600 nm (OD 600 ). Surprisingly, we did not observem easurable light scattering for dimethoxycinnamide 7b between 14 mm and 1.7 mm,b ut intense and spontaneous aggregationf or cinnamide 3 at 510 mm and above,w hich could explain the distinct differenceso bserved by NMR spectroscopy ( Figure 9 ). Sulfonamide 2,a sw ell as the gluco-cinnamide 10,s howedn o light scattering under identical conditions;a ll compounds tested in absence of LecB were also translucent across the entire concentrationr ange. We thus concluded that unsubstituted cinnamide 3 dimerizes or even oligomerizes at high concentrations. These oligomers may act as multivalent anchor points that attract individual LecB tetramersa nd promote aggregation and precipitation. This aggregation can explain the global vanishing of signal intensity in 1 H, 15 N-TROSY-HSQC NMR experimentsw hich was observed for 3. Introduction of the two methoxy-substituents in 7b prevents aggregation of LecB probably because the methoxy groups prevents trong p-pstacking-mediated oligomerization of compound 7b itself.
Conclusions
Cinnamides of d-mannose, such as 3,w ere previously identified as potent glycomimetic inhibitors of LecB, av irulence factor and important biofilm component of the opportunistic pathogen P. aeruginosa. [25] Based on microcalorimetry data and massive line broadeningo bserved in protein NMR spectroscopys ignals in the presence of 3,w hich may result from globalc hanges in the protein structure and/or aggregation of the protein,w e proposed an intercalation binding model. Here, we report an extensive SAR study of substituents at the cinnamide residue of 3 and their influence on binding affinity to LecB. Although ar ather flat SAR was obtained, bindinga ffinity of this class of compounds could be furtheri mprovedf or LecB. The dimethoxy-substituted compound 7b is the most potent derivativew ith as even-fold higher affinity than 1.T he established SAR at the cinnamide residue was, however,n ot sufficient to explain the previously proposed intercalation model of the binding of 3 to LecB. We therefore furthera nalyzed the binding of 3 to LecB using an umber of biophysical methods.
First, the synthesis and biochemical evaluation of the glucoanalog 10 of manno-cinnamide 3 showedt hat the inhibition of LecB by compound 3 is specific and strictly carbohydrate dependent.F urthermore, the data showed that the inhibitory effect on LecB does not result from an unspecific detergent-like effect of thesea mphiphilic compounds.
Kinetic analysis by surface plasmon resonance of the interaction of LecB with the two manno-cinnamides studied here, 3 and 7b,s howed comparable bindingk inetics for both compounds. Very slow on rates close to the detection limit of the SPR machine, as well as comparable intermediate off rates wered etected for both compounds. This kineticd ata suggests as imilar mode of action fort he structurally highly relatedc ompounds cinnamide 3 and dimethoxycinnamide 7b.H owever,t he interaction study using 1 H, 15 N-TROSY HSQC NMR spectra of LecB in presence of 7b showed distinct shifts of about 15 resonances and was therefore in clear contrast to the behavior of its unsubstituted analog 3.A fter extensive search for crystallization conditions for the complex of LecB and cinnamide 3,w es ucceeded in determining the crystal structure of its complex. Sur- www.chemistryopen.org prisingly,asurfacel ocalizationo ft he cinnamide residue in 3 was detected with defined lipophilic interactions and one directed hydrophilic hydrogen bond with LecB. It was not until we performed aggregation assays with the compounds studied and LecB, that we could fully explain the nature behind the effects observed. Onlyu nsubstituted cinnamide 3 aggregated LecB at high ligand concentrations, similar to those used in NMR experiments.W hen two methoxys ubstituents were introduced into the structurally highly similar compound 7b,a ggregation of LecB was no longer observed. Presumably,self-aggregation of compound 3 at high concentrations in aqueous solution via its lipophilic cinnamide moiety lead to an apparent multivalency,w hich precipitated tetravalent LecB. Both cinnamides showed comparablev ery slow on-rates in the surface plasmon resonance (SPR) experiments with LecB, and therefore similar binding modes of 3 and 7b are plausible. Ap ossible conformational change of the protein accounting for these slow on rates is unlikely due to identicalo rientations of the protein in the crystal structures of the apoprotein, [17] LecB with 2 [25] or LecB with 3 (Figures S1 and S2 in the Supporting Information). The overlay of the crystal structures of LecB ands ulfonamide 2 with cinnamide 3 also demonstrates the different areas on the lectin targeted by the sulfonamide and the cinnamide residue, respectively ( Figure S2 in the SupportingI nformation).
Based on these experiments and the crystal structure obtained, we could revise the initially proposedi ntercalation mode forc innamide-based LecB inhibitors. The knowledge gained from this study now allows the structure-based design of follow-up derivatives of the highly potent cinnamide-based class of glycomimeticsa sL ecB inhibitors. Importantly,a ll glycomimetics tested showed extendedr eceptor residence times with half-lives in the 5-20 min range. In contrast, the rapid kinetics of naturalc arbohydrate ligandsw ith half-lives in the 45 srange hamper their use as therapeutics. Thus, the glycomimetics described herep rovide an excellent basis for future developmento fa nti-infectives.
Experimental Section Chemical synthesis
Thin layer chromatography (TLC) was performed using silicagel 60-coated aluminum sheets containing fluorescence indicator (Merck KGaA, Darmstadt, Germany) using UV light (254 nm) and by charring either in anisaldehyde solution (1 %v /v 4-methoxybenzaldehyde, 2% v/v concentrated H 2 SO 4 in EtOH), in aqueous KMnO 4 solution or in am olybdate solution (a 0.02 m solution of Ce(NH 4 ) 4 (SO 4 ) 4 ·2H 2 Oa nd (NH 4 ) 6 Mo 7 O 24 ·4H 2 Oi na queous 10 % H 2 SO 4 )w ith heating. Medium pressure liquid chromatography (MPLC) was performed on aT eledyne Isco Combiflash Rf200 system (Lincoln, USA) using pre-packed silica gel 60 columns from Te ledyne Isco, SiliCycle, or Macherey-Nagel. Commercial chemicals and solvents were used without further purification. Deuterated solvents were purchased from Eurisotop (Saarbrücken, Germany). Nuclear magnetic resonance (NMR) spectroscopy was performed on aB ruker AvanceI II 400 UltraShield spectrometer (Bruker Biospin GmbH, Rheinstetten, Germany) at 400 MHz ( 1 H) or 101 MHz ( 13 C). Chemical shifts are given in ppm and were calibrated on residual solvent peaks as internal standard. [35] Multiplicities were specified as s( singlet), d( doublet), t( triplet), or m( multiplet). The signals were assigned with the help of 1 H, 1 H-COSY,a nd DEPT-135-edited 1 H, 13 C-HSQC experiments. High-resolution mass spectra (HRMS) were obtained on aB ruker micrOTOF II ESI spectrometer,a nd the data were analyzed using DataAnalysis from Bruker.
The NMR and MS data of all synthesized compounds as well as reaction times and mass yields (Table S1 ) can be found in the Supporting Information.
Generalp rocedure for amide couplings
Methyl 6-amino-6-deoxy-a-d-mannopyranoside [25] (50 mg, max. 0.26 mmol), triethylamine (54 mL, 1.5 equiv), and in case of free acids, N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride (EDC·HCl, 73 mg, 1.5 eq), were dissolved in dry dimethylformamide (DMF,1 .5 mL) and cooled to 0 8C. Then, the carboxylic acid, (0.31 mmol, 1.2 equiv) dissolved in DMF (0.5 mL) was added dropwise under argon. After stirring for 1hat 0 8C, the reaction was allowed to warm to rt and was further stirred for 1-3 days. The reactions were quenched with saturated aqueous NH 4 Cl (10 mL) and extracted with EtOAc (1 30mL, 610 mL). The combined organic layers were dried over Na 2 SO 4 ,f iltered, and concentrated in vacuo. The residue was purified by MPLC on silica with CH 2 Cl 2 /EtOH or EtOAc/EtOH. Methyl 6-(2-chlorocinnamido)-6-deoxy-a-d-mannopyranoside (5a) was obtained from 2-chlorocinnamic acid as aw hite solid (30 % over two steps).
Methyl
6-(2-hydroxycinnamido)-6-deoxy-a-d-mannopyranoside (5b)w as obtained from 2-hydroxycinnamic acid as aw hite solid (13 %over two steps).
6-(2-methoxycinnamido)-6-deoxy-a-d-mannopyranoside (5c)w as obtained from 2-methoxycinnamic acid as aw hite solid (56 %over two steps).
Methyl 6-(2-methylcinnamido)-6-deoxy-a-d-mannopyranoside (5d) was obtained from 2-methylcinnamic acid as aw hite solid (52 % over two steps).
Methyl 6-(2-nitrocinnamido)-6-deoxy-a-d-mannopyranoside (5e) was obtained from 2-nitrocinnamic acid as aw hite solid (52 %o ver two steps).
Methyl 6-(2-aminocinnamido)-6-deoxy-a-d-mannopyranoside (5 f). 5e (64 mg, 0.174 mmol) was dissolved in degassed H 2 O, and FeSO 4 ·7 H 2 O( 7eq) and NH 4 OH solution (580 mL, 25 %) were added and stirred under argon atmosphere for 30 min. The suspension was filtered, unsolved residue was washed with NH 4 OH solution (5 2 mL, 5%), and solvent was removed in vacuo. After purification by MPLC, 5f was obtained as ay ellowish solid (45 mg, 0.133 mmol, 77 %).
Methyl 6-(3-chlorocinnamido)-6-deoxy-a-d-mannopyranoside (5g) was obtained from 3-chlorocinnamic acid as aw hite solid (54 % over two steps). Methyl 6-(cinnamido)-6-deoxy-a-d-glucopyranoside (10) . Methyl 6-azido-6-deoxy-a-d-glucopyranoside [30] (9,2 70 mg, 1.23 mmol) was dissolved in MeOH (12 mL) and stirred under hydrogen atmosphere (1 bar) with 10 %P d/C (30 mg, 10 mol %) at rt for 4h.T he mixture was filtered through celite, and the solvent was removed under reduced pressure to give methyl 6-amino-6-deoxy-a-d-glucopyranoside [30] (208 mg) as colorless solid that was subsequently coupled under standard conditions with cinnamic acid (43 %o ver two steps).
Recombinant expression and purification of P. aeruginosa LecB
The protein was expressed and purified as described recently [25] using E. coli BL21 (DE3) and plasmid pET25pa2l. [36] The purified and lyophilized protein was dissolved in Tris-buffered saline supplemented with calcium (TBS/Ca:2 0mm Tris, 137 mm NaCl, 2.6 mm KCl at pH 7.4 supplemented with 0.1 or 1mm CaCl 2 )b efore use, and the concentration was determined by UV spectroscopy at 280 nm using amolar extinction coefficient of 6990 m À1 cm À1 . [37] Recombinant expression and purification of 15 N-labelled LecB was performed using 15 NH 4 Cl as described [25] following ap rocedure by Marley et al. [38] Competitive bindingassay
The competitive binding assay based on fluorescence polarization was performed as previously described by Hauck et al. [25] Briefly, as tock solution of LecB (20 mLo f2 25 nm)a nd fluorescent reporter ligand N-(fluorescein-5-yl)-N'-(a-l-fucopyranosyl ethylen)-thiocarbamide (15 nm)i nT BS/Ca were mixed with serial dilutions (10 mLo f 1mm to 12.8 nm)o ft esting compounds in TBS/Ca in triplicates. After addition of the reagents, the black 384-well microtiter plates (Greiner Bio-One, Germany,c at. no. 781900) were incubated for 8-22 ha tr ti nahumidity chamber.F luorescence emission parallel and perpendicular to the excitation plane was measured on aPheraStar FS (BMG Labtech, Ortenberg, Germany) plate reader or on aT ecan INFINITE F500 plate reader (Tecan Group Ltd.,M ännedorf, Switzerland) with excitation filters at 485 nm and emission filters at 535 nm. For measurements on the Te can INFINITE F500 plate reader,t he G-factor was set on 0.92154 and the gain to 80. The measured intensities were decreased by buffer values, and fluorescence polarization was calculated. The data were analyzed using BMG Labtech MARS software (v.3.01R2, 2013) and/or with GraphPad Prism (GraphPad Software, Inc.,L aJ olla, USA) and fitted according to the four-parameter variable-slope model. Bottom and top plateaus were defined by the standard compounds l-fucose and methyl a-d-mannoside, respectively,a nd the data was reanalyzed with these values fixed. Am inimum of three independent measurements of triplicates each was performed for every ligand.
Microcalorimetry
Isothermal titration calorimetry (ITC) was performed on aM icroCal ITC200 (GE Healthcare, Freiburg, Germany), and the data was analyzed using the MicroCal Origin software (v.7.0, 2009). LecB (300-360 mm)w as dissolved in TBS/Ca (the concentration was verified by UV spectroscopy,s ee above) and placed in the sample cell at 25 8C. The titration was performed with as olution of 7b (3.0-3.5 mm)inthe same buffer.After one preinjection (0.4 mL), 19 injections of 2 mLa nd 4seach with as pacing of 460 or 480 sw ere performed. Three independent titrations were run.
Surfaceplasmon resonance (SPR) measurements
SPR binding experiments were performed on aB iacore X100 instrument (GE Healthcare, Freiburg, Germany) at 25 8Ci nHepesbuffered saline (HBS:1 0mm Hepes/NaOH, pH 7.4, 150 mm NaCl, 0.05 %T ween 20) at aflow rate of 30 mLm in
À1
.LecB was biotinylated using EZ-Link NHS-LC-LC-Biotin (Pierce, cat. no. 21343) following the manufacturer'sc onditions. Streptavidin (7000 RU) was immobilized on ar esearch-grade CM5 chip using standard procedures, and 4200 RU of biotinylated LecB were captured on channel 2. Binding experiments were performed with the LecB-captured channel 2, and plots represent the subtracted data (channel 2-channel 1). Binding studies consisted of the injection (association 180 s, dissociation 180 s) of various concentrations of inhibitor (120 nm-75 mm for compounds 2, 3,a nd 7b,o r3mm-1.8 mm for 1)i nt he single cycle mode. Binding was measured as resonance units over time after blank subtraction, and data were then evaluated by using the Biacore X100 evaluation software (version 2.0).
Biomolecular NMR spectroscopy
For NMR experiments, 15 N-LecB (500 mm)i nT BS/Ca was supplemented with 5% D 2 O( Eurisotop, Germany). NMR spectra were measured in standard NMR tubes (5 mm) in the presence and absence of ligand (250 or 500 mm)a t3 00 K. NMR experiments were performed with aB ruker AvanceI II 600 MHz spectrometer equipped with an inverse H/C/N-TCI-cryoprobe (5 mm) with actively shielded z-gradient. 1 H, 15 N-TROSY-HSQC spectra were acquired with 256 increments in the indirect dimension with 16 scans per increment. All NMR spectra were processed and analyzed with Bruker's To pSpin software (version 3.0).
Circular dichroism (CD) spectroscopy
Protein samples for CD measurements and melting assays were purified as described above. CD spectra were measured on aJ ASCO-J1500 spectropolarimeter (Gross-Umstadt, Germany) equipped with aP TC-510 Peltier Thermostatted Single Cell Holder using a1mm optical path. Protein samples were prepared as a3 4.8 mm solution in TBS buffer supplemented with 1mm CaCl 2 in ar eaction volume of 300 mLw ith or without 100 mm compound 3.S cans were performed at 37 8Co ver aw avelength range of 200-280 nm (three accumulations) with as canning speed of 100 nm min
À1
,1nm data pitch, and 1nmb andwidth. For thermal denaturation, samples were prepared as described above. Folded samples were heated from 37 8Ct o9 68Cw ith ah eating rate of 2 8Cm in
.T he CD signal at 229 nm was recorded every 1 8C.
Crystallizationa nd structure determination
Crystals of recombinant LecB from P. aeruginosa were obtained by the hanging drop vapor diffusion method using 2 mLo fd rops containing a5 0:50 (v/v)m ix of protein and reservoir solution at 19 8C. The protein at 10 mg mL À1 was incubated with 15.3 mm of 3 in H 2 Oa nd 100 mm CaCl 2 during 1h at rt prior to co-crystallization. Clusters were obtained in as olution containing 25 %P EG6K, 1 m LiCl, and 0.1 m citric acid at pH 3.8. Ab roken tip was directly mounted in ac ryoloop and flash-frozen in liquid nitrogen. Diffraction data were collected at 100 Ka tt he European Synchrotron Radiation Facility (Grenoble, France) on beamline BM30 Au sing aM ARCCD detector.T he data were processed using XDS. [39] All further computing was performed using the CCP4 suite. [40] Data quality statistics are summarized in Ta ble 3. The structure was solved by molecular replacement using PHASER and the tetramer coordinates of 3ZDV as search model. [25, 41] Five percent of the observations were set aside for cross-validation analysis, and hydrogen atoms were added in their riding positions and used for geometry and structure-factor calculations. The structure was refined using restrained maximum likelihood refinement in REFMAC 5.8 [42] iterated with manual rebuilding in Coot. [43] Incorporation of the ligand was performed after inspection of the 2Fo-DFc weighted maps. Water molecules, introduced automatically using Coot, were inspected manually.T he stereochemical quality of the models was assessed with the program Molprobity, [44] and coordinates were deposited in the Protein Data Bank under code 5A3O.
Aggregation assay
As tock solution of LecB (40 mL, 200 mm in TBS/Ca) was mixed with serial dilutions of testing compounds (20 mLo ffinal test concentrations of 1.7 mm to 13.5 mm)i nto at ransparent F-bottom 384-well microtiter plate (Greiner Bio-One, Germany,c at. no. 781901) in duplicates. The highest concentration of each inhibitor was included without LecB in duplicates as control. Absorbance was measured on aP heraStar FS (BMG Labtech, Germany) plate reader at 600 nm after 30 min and 4hof incubation at rt and did not show differences between the two time points. The data were analyzed using BMG Labtech MARS software and GraphPad Prism.
